|
1
|
Meran S and Steadman R: Fibroblasts and
myofibroblasts in renal fibrosis. Int J Exp Pathol. 92:158–167.
2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu Y: Cellular and molecular mechanisms
of renal fibrosis. Nat Rev Nephrol. 7:684–696. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
TGF-β: The master regulator of fibrosis. Nat Rev Nephrol.
12:325–338. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yang J and Liu Y: Dissection of key events
in tubular epithelial to myofibroblast transition and its
implications in renal interstitial fibrosis. Am J Pathol.
159:1465–1475. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Friedman SL, Sheppard D, Duffield JS and
Violette S: Therapy for fibrotic diseases: Nearing the starting
line. Sci Transl Med. 5(167sr161)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sutariya B, Jhonsa D and Saraf MN: TGF-β:
The connecting link between nephropathy and fibrosis.
Immunopharmacol Immunotoxicol. 38:39–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hills CE and Squires PE: The role of TGF-β
and epithelial-to mesenchymal transition in diabetic nephropathy.
Cytokine Growth Factor Rev. 22:131–139. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Nishioka T, Eustace A and West C: Lysyl
oxidase: From basic science to future cancer treatment. Cell Struct
Funct. 37:75–80. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Maki JM, Sormunen R, Lippo S,
Kaarteenaho-Wiik R, Soininen R and Myllyharju J: Lysyl oxidase is
essential for normal development and function of the respiratory
system and for the integrity of elastic and collagen fibers in
various tissues. Am J Pathol. 167:927–936. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ahn SG, Dong SM, Oshima A, Kim WH, Lee HM,
Lee SA, Kwon SH, Lee JH, Lee JM, Jeong J, et al: LOXL2 expression
is associated with invasiveness and negatively influences survival
in breast cancer patients. Breast Cancer Res Treat. 141:89–99.
2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cuevas EP, Moreno-Bueno G, Canesin G,
Santos V, Portillo F and Cano A: LOXL2 catalytically inactive
mutants mediate epithelial-to-mesenchymal transition. Biol Open.
3:129–137. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cuevas EP, Eraso P, Mazon MJ, Santos V,
Moreno-Bueno G, Cano A and Portillo F: LOXL2 drives
epithelial-mesenchymal transition via activation of IRE1-XBP1
signalling pathway. Sci Rep. 7(44988)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wen X, Liu Y, Bai Y, Li M, Fu Q and Zheng
Y: LOXL2, a copper-dependent monoamine oxidase, activates lung
fibroblasts through the TGF-β/Smad pathway. Int J Mol Med.
42:3530–3541. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cosgrove D, Dufek B, Meehan DT, Delimont
D, Hartnett M, Samuelson G, Gratton MA, Phillips G, MacKenna DA and
Bain G: Lysyl oxidase like-2 contributes to renal fibrosis in
Col4alpha3/Alport mice. Kidney Int. 94:303–314. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Choi SE, Jeon N, Choi HY, Shin JI, Jeong
HJ and Lim BJ: Lysyl oxidaselike 2 is expressed in kidney tissue
and is associated with the progression of tubulointerstitial
fibrosis. Mol Med Rep. 16:2477–2482. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Long DA, Woolf AS, Suda T and Yuan HT:
Increased renal angiopoietin-1 expression in folic acid-induced
nephrotoxicity in mice. J Am Soc Nephrol. 12:2721–2731.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Stallons LJ, Whitaker RM and Schnellmann
RG: Suppressed mitochondrial biogenesis in folic acid-induced acute
kidney injury and early fibrosis. Toxicol Lett. 224:326–332.
2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang W, Li Z, Chen Y, Wu H, Zhang S and
Chen X: Prediction value of serum NGAL in the diagnosis and
prognosis of experimental acute and chronic kidney injuries.
Biomolecules. 10(981)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Barry-Hamilton V, Spangler R, Marshall D,
McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien
H, Wai C, et al: Allosteric inhibition of lysyl oxidase-like-2
impedes the development of a pathologic microenvironment. Nat Med.
16:1009–1017. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Yen CL, Li YJ, Wu HH, Weng CH, Lee CC,
Chen YC, Chang MY, Yen TH, Hsu HH, Hung CC, et al: Stimulation of
transforming growth factor-beta-1 and contact with type I collagen
cooperatively facilitate irreversible transdifferentiation in
proximal tubular cells. Biomed J. 39:39–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Van Bergen T, Marshall D, Van de Veire S,
Vandewalle E, Moons L, Herman J, Smith V and Stalmans I: The role
of LOX and LOXL2 in scar formation after glaucoma surgery. Invest
Ophthalmol Vis Sci. 54:5788–5796. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Meissner EG, McLaughlin M, Matthews L,
Gharib AM, Wood BJ, Levy E, Sinkus R, Virtaneva K, Sturdevant D,
Martens C, et al: Simtuzumab treatment of advanced liver fibrosis
in HIV and HCV-infected adults: Results of a 6-month open-label
safety trial. Liver Int. 36:1783–1792. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fu Y, Tang C, Cai J, Chen G, Zhang D and
Dong Z: Rodent models of AKI-CKD transition. Am J Physiol Renal
Physiol. 315:F1098–F1106. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Walkin L, Herrick SE, Summers A, Brenchley
PE, Hoff CM, Korstanje R and Margetts PJ: The role of mouse strain
differences in the susceptibility to fibrosis: A systematic review.
Fibrogenesis Tissue Repair. 6(18)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nguyen LT, Saad S, Shi Y, Wang R, Chou
ASY, Gill A, Yao Y, Jarolimek W and Pollock CA: Lysyl oxidase
inhibitors attenuate cyclosporin A-induced nephropathy in mouse.
Sci Rep. 11(12437)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bottinger EP and Bitzer M: TGF-beta
signaling in renal disease. J Am Soc Nephrol. 13:2600–2610.
2002.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pohlers D, Brenmoehl J, Loffler I, Müller
CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW and Wolf G:
TGF-beta and fibrosis in different organs-molecular pathway
imprints. Biochim Biophys Acta. 1792:746–756. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cheng M, Liu F, Peng Y, Chen J, Chen G,
Xiao L and Liu H: Construction of a CTGF and RFP-coexpressed renal
tubular epithelial cell and its application on evaluation of
CTGF-specific siRNAs on epithelial-mesenchymal transition. Urology.
83:1443.e1–e8. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Vadasz Z, Kessler O, Akiri G,
Gengrinovitch S, Kagan HM, Baruch Y, Izhak OB and Neufeld G:
Abnormal deposition of collagen around hepatocytes in Wilson's
disease is associated with hepatocyte specific expression of lysyl
oxidase and lysyl oxidase like protein-2. J Hepatol. 43:499–507.
2005.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Burns WC, Twigg SM, Forbes JM, Pete J,
Tikellis C, Thallas-Bonke V, Thomas MC, Cooper ME and Kantharidis
P: Connective tissue growth factor plays an important role in
advanced glycation end product-induced tubular
epithelial-to-mesenchymal transition: Implications for diabetic
renal disease. J Am Soc Nephrol. 17:2484–2494. 2006.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mack M and Yanagita M: Origin of
myofibroblasts and cellular events triggering fibrosis. Kidney Int.
87:297–307. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Qi W, Chen X, Poronnik P and Pollock CA:
Transforming growth factor-beta/connective tissue growth factor
axis in the kidney. Int J Biochem Cell Biol. 40:9–13.
2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kriz W, Kaissling B and Le Hir M:
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or
fantasy? J Clin Invest. 121:468–474. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Grande MT, Sanchez-Laorden B, Lopez-Blau
C, De Frutos CA, Boutet A, Arévalo M, Rowe RG, Weiss SJ,
López-Novoa JM and Nieto MA: Snail1-induced partial
epithelial-to-mesenchymal transition drives renal fibrosis in mice
and can be targeted to reverse established disease. Nat Med.
21:989–997. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tang WB, Ling GH, Sun L, Zhang K, Zhu X,
Zhou X and Liu FU: Smad anchor for receptor activation regulates
high glucose-induced EMT via modulation of Smad2 and Smad3
activities in renal tubular epithelial cells. Nephron. 130:213–220.
2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Weiss WA, Taylor SS and Shokat KM:
Recognizing and exploiting differences between RNAi and
small-molecule inhibitors. Nat Chem Biol. 3:739–744.
2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Peinado H, Cruz MDC, Olmeda D, Csiszar K,
Fong KSK, Vega S, Nieto MA, Cano A and Portillo F: A molecular role
for lysyl oxidase-like 2 enzyme in snail regulation and tumor
progression. EMBO J. 24:3446–3458. 2005.PubMed/NCBI View Article : Google Scholar
|
